BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21150283)

  • 1. A KV2.1 gating modifier binding assay suitable for high throughput screening.
    Schmalhofer WA; Ratliff KS; Weinglass A; Kaczorowski GJ; Garcia ML; Herrington J
    Channels (Austin); 2009 Nov; 3(6):437-47. PubMed ID: 21150283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tarantula toxin GxTx detains K
    Tilley DC; Angueyra JM; Eum KS; Kim H; Chao LH; Peng AW; Sack JT
    J Gen Physiol; 2019 Mar; 151(3):292-315. PubMed ID: 30397012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoselective tarantula toxins report voltage activation of wild-type ion channels in live cells.
    Tilley DC; Eum KS; Fletcher-Taylor S; Austin DC; Dupré C; Patrón LA; Garcia RL; Lam K; Yarov-Yarovoy V; Cohen BE; Sack JT
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4789-96. PubMed ID: 25331865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels.
    Tao H; Chen JJ; Xiao YC; Wu YY; Su HB; Li D; Wang HY; Deng MC; Wang MC; Liu ZH; Liang SP
    Biochemistry; 2013 Oct; 52(42):7439-48. PubMed ID: 24044413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kv2 channel regulation of action potential repolarization and firing patterns in superior cervical ganglion neurons and hippocampal CA1 pyramidal neurons.
    Liu PW; Bean BP
    J Neurosci; 2014 Apr; 34(14):4991-5002. PubMed ID: 24695716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of GxTX-1E, a high-affinity tarantula toxin interacting with voltage sensors in Kv2.1 potassium channels .
    Lee S; Milescu M; Jung HH; Lee JY; Bae CH; Lee CW; Kim HH; Swartz KJ; Kim JI
    Biochemistry; 2010 Jun; 49(25):5134-42. PubMed ID: 20509680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of spider gating modifier peptides with voltage-gated potassium channels.
    Huang PT; Shiau YS; Lou KL
    Toxicon; 2007 Feb; 49(2):285-92. PubMed ID: 17113615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JZTX-XIII, a Kv channel gating modifier toxin from Chinese tarantula Chilobrachys jingzhao.
    Yuan C; Liu Z; Hu W; Gao T; Liang S
    Toxicon; 2012 Feb; 59(2):265-71. PubMed ID: 22155305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets.
    Li XN; Herrington J; Petrov A; Ge L; Eiermann G; Xiong Y; Jensen MV; Hohmeier HE; Newgard CB; Garcia ML; Wagner M; Zhang BB; Thornberry NA; Howard AD; Kaczorowski GJ; Zhou YP
    J Pharmacol Exp Ther; 2013 Feb; 344(2):407-16. PubMed ID: 23161216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sodium channel gating by trapping the domain II voltage sensor with protoxin II.
    Sokolov S; Kraus RL; Scheuer T; Catterall WA
    Mol Pharmacol; 2008 Mar; 73(3):1020-8. PubMed ID: 18156314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jingzhaotoxin-35, a novel gating-modifier toxin targeting both Nav1.5 and Kv2.1 channels.
    Wei P; Xu C; Wu Q; Huang L; Liang S; Yuan C
    Toxicon; 2014 Dec; 92():90-6. PubMed ID: 25449098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localization.
    Thiffault I; Speca DJ; Austin DC; Cobb MM; Eum KS; Safina NP; Grote L; Farrow EG; Miller N; Soden S; Kingsmore SF; Trimmer JS; Saunders CJ; Sack JT
    J Gen Physiol; 2015 Nov; 146(5):399-410. PubMed ID: 26503721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure and functional characterization of SGTx1, a modifier of Kv2.1 channel gating.
    Lee CW; Kim S; Roh SH; Endoh H; Kodera Y; Maeda T; Kohno T; Wang JM; Swartz KJ; Kim JI
    Biochemistry; 2004 Feb; 43(4):890-7. PubMed ID: 14744131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of use-dependent Kv2 channel inhibition by RY785.
    Marquis MJ; Sack JT
    J Gen Physiol; 2022 Jun; 154(6):. PubMed ID: 35435946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and mechanism of Chinese tarantula toxins on the Kv2.1 potassium channels.
    Yuan C; Yang S; Liao Z; Liang S
    Biochem Biophys Res Commun; 2007 Jan; 352(3):799-804. PubMed ID: 17150181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial blockade of Kv2.1 channel potentiates GLP-1's insulinotropic effects in islets and reduces its dose required for improving glucose tolerance in type 2 diabetic male mice.
    Sukma Rita R; Dezaki K; Kurashina T; Kakei M; Yada T
    Endocrinology; 2015 Jan; 156(1):114-23. PubMed ID: 25337656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants for the tarantula toxin jingzhaotoxin-I interacting with potassium channel Kv2.1.
    Tao H; Wu Y; Deng M; He J; Wang M; Xiao Y; Liang S
    Toxicon; 2013 Mar; 63():129-36. PubMed ID: 23246579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Interactions between Tarantula Toxins and Low-Voltage-Activated Calcium Channels.
    Salari A; Vega BS; Milescu LS; Milescu M
    Sci Rep; 2016 Apr; 6():23894. PubMed ID: 27045173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels.
    Priest BT; Blumenthal KM; Smith JJ; Warren VA; Smith MM
    Toxicon; 2007 Feb; 49(2):194-201. PubMed ID: 17087985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tarantula toxins for subtypes of voltage-dependent potassium channels in the Kv2 and Kv4 subfamilies.
    Escoubas P; Diochot S; Célérier ML; Nakajima T; Lazdunski M
    Mol Pharmacol; 2002 Jul; 62(1):48-57. PubMed ID: 12065754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.